Connor, Clark & Lunn Investment Management (CC&L)’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $529K | Buy |
|
|||||
|
2023
Q4 | $227K | Sell |
|
|||||
|
2023
Q3 | $521K | Sell |
|
|||||
|
2023
Q2 | $479K | Sell |
|
|||||
|
2023
Q1 | $419K | Sell |
|
|||||
|
2022
Q4 | $429K | Buy |
|
|||||
|
2022
Q3 | $414K | Buy |
|
|||||
|
2022
Q2 | $427K | Buy |
|
|||||
|
2022
Q1 | $254K | Buy |
|
|||||
|
2021
Q4 | $264K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $169K | Buy |
|